This inventor holds 1 USPTO granted patent. Top assignee: Kyowa Hakko Kirin Co., Limited. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Kenji Iwata: Innovator in Pharmaceutical Composition
Introduction
Kenji Iwata is a notable inventor based in Chiyoda-ku, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patent work. His expertise and dedication to research have positioned him as a valuable asset in the industry.
Latest Patents
Kenji Iwata holds a patent for a pharmaceutical composition containing an arylalkylamine compound. This invention provides a pharmaceutical composition comprising (4-{(3S)-3-[(1R)-1-(naphthalen-1-yl)ethylamino]pyrrolidin-1-yl}phenyl)acetic acid (Compound A) or a pharmacologically acceptable salt thereof and a diluent. This patent showcases his commitment to advancing medical science and improving therapeutic options.
Career Highlights
Iwata is associated with Kyowa Hakko Kirin Co., Limited, a prominent company in the pharmaceutical sector. His work at this organization has allowed him to collaborate with other talented professionals and contribute to groundbreaking research and development.
Collaborations
Some of his notable coworkers include Shinji Tanimura and Hiroko Yoshii. Their collective efforts in research and development have further enhanced the innovative capabilities of their team.
Conclusion
Kenji Iwata's contributions to pharmaceutical innovation through his patent work exemplify his dedication to improving healthcare solutions. His collaboration with esteemed colleagues and his role at Kyowa Hakko Kirin Co., Limited highlight his importance in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile